Soligenix
SNGX
#10983
Rank
โ‚ฌ6.72 M
Marketcap
0,31ย โ‚ฌ
Share price
-1.95%
Change (1 day)
-80.14%
Change (1 year)

Revenue for Soligenix (SNGX)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of โ‚ฌ0.11 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Soligenix from 1998 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 โ‚ฌ0.11 M-51.66%
2023 โ‚ฌ0.23 M-0.18%
2022 โ‚ฌ0.23 M691.41%
2021 โ‚ฌ0.02 M-98.12%
2020 โ‚ฌ1.56 M-45.32%
2019 โ‚ฌ2.87 M-17.19%
2018 โ‚ฌ3.46 M-3.78%
2017 โ‚ฌ3.6 M-63.73%
2016 โ‚ฌ9.93 M23.87%
2015 โ‚ฌ8.01 M38.48%
2014 โ‚ฌ5.79 M148.05%
2013 โ‚ฌ2.33 M-1.79%
2012 โ‚ฌ2.37 M-59.71%
2011 โ‚ฌ5.9 M302.98%
2010 โ‚ฌ1.46 M-25.5%
2009 โ‚ฌ1.96 M18.94%
2008 โ‚ฌ1.65 M91.75%
2007 โ‚ฌ0.86 M-50.84%
2006 โ‚ฌ1.75 M-30.22%
2005 โ‚ฌ2.51 M
1999 โ‚ฌ0 M-100%
1998 โ‚ฌ0.33 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ87.33 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ56.80 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ50.69 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
โ‚ฌ0.2 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.07 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ15.44 BN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
โ‚ฌ0.56 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.66 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA